150 related articles for article (PubMed ID: 24061634)
1. Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men.
Hughes L; Ruth K; Rebbeck TR; Giri VN
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):308-14. PubMed ID: 24061634
[TBL] [Abstract][Full Text] [Related]
2. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection.
Hughes L; Zhu F; Ross E; Gross L; Uzzo RG; Chen DY; Viterbo R; Rebbeck TR; Giri VN
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):53-60. PubMed ID: 22144497
[TBL] [Abstract][Full Text] [Related]
3. Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer.
Chang BL; Hughes L; Chen DY; Gross L; Ruth K; Giri VN
BJU Int; 2014 May; 113(5b):E150-6. PubMed ID: 23937305
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in microRNA target sites of 37 selected cancer-related genes and the risk of cervical cancer.
Mi Y; Wang L; Zong L; Pei M; Lu Q; Huang P
PLoS One; 2014; 9(1):e86061. PubMed ID: 24465869
[TBL] [Abstract][Full Text] [Related]
5. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.
Giri VN; Egleston B; Ruth K; Uzzo RG; Chen DY; Buyyounouski M; Raysor S; Hooker S; Torres JB; Ramike T; Mastalski K; Kim TY; Kittles R
Cancer Prev Res (Phila); 2009 Mar; 2(3):244-50. PubMed ID: 19240249
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val.
Giri VN; Ruth K; Hughes L; Uzzo RG; Chen DY; Boorjian SA; Viterbo R; Rebbeck TR
BJU Int; 2011 Feb; 107(3):466-70. PubMed ID: 20735386
[TBL] [Abstract][Full Text] [Related]
7. Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population.
Azimzadeh P; Romani S; Mohebbi SR; Mahmoudi T; Vahedi M; Fatemi SR; Zali N; Zali MR
Cancer Genet; 2012 Oct; 205(10):501-7. PubMed ID: 22939228
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study.
Wang Y; Ray AM; Johnson EK; Zuhlke KA; Cooney KA; Lange EM
Prostate; 2011 Feb; 71(3):225-31. PubMed ID: 20717903
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer screening in high-risk men: African American Hereditary Prostate Cancer Study Network.
Weinrich SP
Cancer; 2006 Feb; 106(4):796-803. PubMed ID: 16411222
[TBL] [Abstract][Full Text] [Related]
10. Genetically adjusted prostate-specific antigen values may prevent delayed biopsies in African-American men.
Donin NM; Loeb S; Cooper PR; Roehl KA; Baumann NA; Catalona WJ; Helfand BT
BJU Int; 2014 Dec; 114(6b):E50-E55. PubMed ID: 24712975
[TBL] [Abstract][Full Text] [Related]
11. Fine-mapping of IL16 gene and prostate cancer risk in African Americans.
Batai K; Shah E; Murphy AB; Newsome J; Ruden M; Ahaghotu C; Kittles RA
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2059-68. PubMed ID: 22923025
[TBL] [Abstract][Full Text] [Related]
12. Association of CD14 variant with prostate cancer in African American men.
Mason TE; Ricks-Santi L; Chen W; Apprey V; Joykutty J; Ahaghotu C; Kittles R; Bonney G; Dunston GM
Prostate; 2010 Feb; 70(3):262-9. PubMed ID: 19830784
[TBL] [Abstract][Full Text] [Related]
13. INSPstI polymorphism and prostate cancer in African-American men.
Claeys GB; Sarma AV; Dunn RL; Zuhlke KA; Beebe-Dimmer J; Montie JE; Wojno KJ; Schottenfeld D; Cooney KA
Prostate; 2005 Sep; 65(1):83-7. PubMed ID: 15880482
[TBL] [Abstract][Full Text] [Related]
14. Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.
Paris PL; Kupelian PA; Hall JM; Williams TL; Levin H; Klein EA; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):901-5. PubMed ID: 10548319
[TBL] [Abstract][Full Text] [Related]
15. Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men.
Bangsi D; Zhou J; Sun Y; Patel NP; Darga LL; Heilbrun LK; Powell IJ; Severson RK; Everson RB
Urol Oncol; 2006; 24(1):21-7. PubMed ID: 16414488
[TBL] [Abstract][Full Text] [Related]
16. Genetic Hitchhiking and Population Bottlenecks Contribute to Prostate Cancer Disparities in Men of African Descent.
Lachance J; Berens AJ; Hansen MEB; Teng AK; Tishkoff SA; Rebbeck TR
Cancer Res; 2018 May; 78(9):2432-2443. PubMed ID: 29438991
[TBL] [Abstract][Full Text] [Related]
17. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.
Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE
PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779
[TBL] [Abstract][Full Text] [Related]
18. Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study.
Giorgi EE; Stram DO; Taverna D; Turner SD; Schumacher F; Haiman CA; Lum-Jones A; Tirikainen M; Caberto C; Duggan D; Henderson BE; Le Marchand L; Cheng I
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1928-32. PubMed ID: 24904019
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study.
Sarma AV; Dunn RL; Lange LA; Ray A; Wang Y; Lange EM; Cooney KA
Prostate; 2008 Feb; 68(3):296-305. PubMed ID: 18163429
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population.
Kaplan DJ; Boorjian SA; Ruth K; Egleston BL; Chen DY; Viterbo R; Uzzo RG; Buyyounouski MK; Raysor S; Giri VN
BJU Int; 2010 Feb; 105(3):334-7. PubMed ID: 19709072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
